
Production of generic medicines and health products, primarily manufactured in France and Europe.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
PHOENIX Pharma France
B
Distribution of pharmaceutical products to pharmacies in France and across Europe.
Pharma & Beauty Group
B
Development and production of formulas for the health and beauty sectors, including advanced manufacturing facilities in France.
LFB
B
Development, manufacturing, and commercialization of plasma-derived biomedicines. Focus on public health and French health sovereignty.
Initiatives identified among leaders
Stratégie marque employeur pour réduire le turnover et attirer des talents
“La stratégie Marque Employeur de LFB France, lancé...” - LFBMajorité féminine et représentation équilibrée dans la direction
“Promotion de l’égalité professionnelle avec une ma...” - Pharma & Beauty GroupRéduction de 43 % des émissions GES scopes 1, 2 et 3 d'ici 2030
“LFB s'est engagé à réduire ses émissions de gaz à ...” - LFB64% of similar organizations communicate on CSR issues
+644 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports